(Q47827742)

English

Biochemical outcome for hormone-naïve intermediate-risk prostate cancer managed with permanent interstitial brachytherapy and supplemental external beam radiation.

scientific article published in January 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/15062177

Biochemical outcome for hormone-naïve intermediate-risk prostate cancer managed with permanent interstitial brachytherapy and supplemental external beam radiation. (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/15062177

1 reference

based on heuristic

inferred from title

author name string

Gregory S Merrick

1

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/15062177

Wayne M Butler

2

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/15062177

Jonathan H Lief

3

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/15062177

Robert W Galbreath

4

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/15062177

Edward Adamovich

5

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/15062177

publication date

1 January 2002

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/15062177

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/15062177

1

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/15062177

2

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/15062177

95-101

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/15062177

Palladium-103 brachytherapy for prostate carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1538-4721%2802%2900016-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Modern prostate brachytherapy. Prostate specific antigen results in 219 patients with up to 12 years of observed follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS1538-4721%2802%2900016-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic role of serum prostatic acid phosphatase for 103Pd-based radiation for prostatic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1538-4721%2802%2900016-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Prostate specific antigen based disease control following ultrasound guided 125iodine implantation for stage T1/T2 prostatic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1538-4721%2802%2900016-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Five-year biochemical outcome and toxicity with transperineal CT-planned permanent I-125 prostate implantation for patients with localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1538-4721%2802%2900016-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Five-year biochemical outcome following permanent interstitial brachytherapy for clinical T1-T3 prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1538-4721%2802%2900016-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Brachytherapy for clinically localized prostate cancer: results at 7- and 8-year follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS1538-4721%2802%2900016-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Dosimetry of interstitial brachytherapy sources: recommendations of the AAPM Radiation Therapy Committee Task Group No. 43. American Association of Physicists in Medicine.

1 reference

https://api.crossref.org/works/10.1016%2FS1538-4721%2802%2900016-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Seed fixity in the prostate/periprostatic region following brachytherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1538-4721%2802%2900016-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of seed loading approaches in prostate brachytherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1538-4721%2802%2900016-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Potential role of various dosimetric quality indicators in prostate brachytherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1538-4721%2802%2900016-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Failure-free survival following brachytherapy alone or external beam irradiation alone for T1-2 prostate tumors in 2222 patients: results from a single practice

1 reference

https://api.crossref.org/works/10.1016%2FS1538-4721%2802%2900016-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1538-4721%2802%2900016-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Dose effects of seeds placement deviations from pre-planned positions in ultrasound guided prostate implants

1 reference

https://api.crossref.org/works/10.1016%2FS1538-4721%2802%2900016-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Examining the role of neoadjuvant androgen deprivation in patients undergoing prostate brachytherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1538-4721%2802%2900016-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Survival advantage from higher-dose radiation therapy for clinically localized prostate cancer treated on the Radiation Therapy Oncology Group trials

1 reference

https://api.crossref.org/works/10.1016%2FS1538-4721%2802%2900016-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1538-4721(02)00016-8

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/15062177

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/15062177

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47827742&oldid=1418453247"